Humana Inc. (HUM)

Humana Inc.'s stock price has experienced a significant decline in the past six months. The stock has fallen by approximately 24.28% over the last six months and around 29.25% over the past year. Its 52-week trading range has been between $186.00 and $315.35. Key events impacting the stock include Morgan Stanley downgrading Humana from "equalweight" to "underweight" in February 2026, Wells Fargo downgrading Humana to "Equal-Weight" from "Overweight" in January 2026, and analyst projections of a quarterly loss of -$4.01 per share for Q4 2025.

Demand for Humana's products and services exhibits seasonality, particularly around the Annual Enrollment Period (AEP). The company hires seasonal staff to manage the increased volume of applications, inquiries, and enrollment-related tasks during this time. Training for these seasonal roles typically begins in August, and assignments can last up to six months, indicating a heightened demand for enrollment services in the latter half of the year.

Humana Inc. is an American for-profit health insurance company headquartered in Louisville, Kentucky, operating in the Healthcare sector. It is one of the largest private health insurers in the United States. The company's business is divided into two segments: Insurance and CenterWell. The Insurance segment focuses on health insurance services, with a significant portion of its medical membership derived from government-sponsored programs. The CenterWell segment encompasses payor-agnostic healthcare services, including pharmacy benefit management, senior-focused primary care centers, and home health and hospice services.

Humana Inc. maintains a substantial market presence across the United States, with its medical membership primarily concentrated in the U.S. Humana has an expanding Medicaid footprint, organically growing its presence to 13 states, including recent wins in Georgia and Texas.

Humana has demonstrated a commitment to sustainability by expanding its validated science-based targets (SBT) with a new financial institution target approved by the Science Based Targets initiative (SBTi) in June 2025. This target aims to reduce emissions from investments and lending activities, aligning its financial influence with operational impact. Humana revised its investment policy to incorporate SBTi-aligned climate commitments. The company emphasizes its commitment to putting health first for its customers and communities.

Institutional investors hold a significant majority of Humana Inc.'s stock, with institutional ownership reported as high as 99.23% and 96.64%. Major institutional owners include The Vanguard Group Inc., Dodge & Cox, and BlackRock, Inc. Insider ownership is relatively low at 1.05%.